Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in AVBP — ArriVent BioPharma, Inc.

CIK 1214717 BOSTON, MA
Back to AVBP Full portfolio

Position in AVBP

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$33,789,026
+$15,248,776 QoQ
Shares Held
972,626
+21.0% QoQ
Ownership
1.97%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 158 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. AVBP ranks #105 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in AVBP

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $33,789,026 972,626
2026-03-31 $18,540,250 803,652
2025-12-31 $15,160,801 753,519
2025-09-30 $13,215,513 716,288
2025-06-30 $12,975,311 596,018
2025-03-31 $11,362,529 614,523
2024-12-31 $15,882,288 596,182
2024-09-30 $14,033,377 597,165
2024-06-30 $4,358,210 234,944
2024-03-31 $4,019,375 225,049